Thyroid therapy
-
Mimicry: The idol of T3-T4 combo therapy 2004-2014
They say that history is written by the victors. Not always. Sometimes histories are written by advocates for the oppressed and disenfranchised. A common theme on our website is the need to see current practices and thyroid therapy challenges in light of thyroid therapy history. Instead of trusting histories written by scientists, one ought to…
-
The foundations of synthetic T3-T4 therapy in the 1990s
A trend in thyroid therapy, sparked by a 1995 rat study, attempted to mimic a narrowly estimated T3:T4 ratio secreted by human thyroid glands. This trend was based on a theory of pharmaceutical mimicry of “the” thyroid gland. Its proponents chose to represent every human being’s thyroid gland by the narrow statistical average secretion ratio…
-
RLC Labs issues Nature-Throid and WP-thyroid recall for subpotency
Oh my. Now another American desiccated thyroid (NDT) brand recall? Earlier this year, Acella’s NP thyroid was found to be superpotent (over 110% on the T3 content), and they issued a voluntary recall. Now, as of August 25, 2020, Nature-Throid and/or WP-Thyroid are sub-potent, so their manufacturer RLC Labs is issuing a voluntary recall. QUOTE:…
-
Q&A. Dosing T3 in light of circadian rhythm
[Post updated Aug 5, 2020 with additional sample images.] Question In response to my post The Significance of the TSH-T3 Circadian Rhythm, Julien wrote: “Thank you for such an informative article. If I interpreted this correctly, for the hypothyroid patients on combined T3+T4 therapy, it would seem that taking the T4 dose early in the…
-
LT3 monotherapy withdrawal: Clearance and effects
How long does it take for the final dose of synthetic LT3 (Liothyronine) hormone to clear from blood, and how much suffering might a withdrawal cause? This is an important question for many people who dose LT3. They want to know what would happen if they unexpectedly ran out of supply due to a pharmaceutical…